Indivior (LON:INDV) Stock Crosses Below 200 Day Moving Average – Should You Sell?

Indivior PLC (LON:INDVGet Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,060.53 ($13.75) and traded as low as GBX 678 ($8.79). Indivior shares last traded at GBX 685.50 ($8.89), with a volume of 675,354 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,500 ($19.45) price target on shares of Indivior in a research note on Thursday, September 5th.

View Our Latest Stock Analysis on INDV

Indivior Trading Up 3.5 %

The business’s 50 day moving average price is GBX 744.61 and its two-hundred day moving average price is GBX 1,048.04. The company has a current ratio of 0.85, a quick ratio of 1.52 and a debt-to-equity ratio of 2,790.00. The company has a market capitalization of £912.35 million, a price-to-earnings ratio of -886.88, a P/E/G ratio of -5.57 and a beta of 0.19.

Indivior Company Profile

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Featured Articles

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.